Matches in Nanopublications for { ?s ?p "DDI between Voriconazole and Meloxicam - Voriconazole may increase the serum concentration of meloxicam by decreasing its metabolism via CYP2C9 and CYP3A4. Monitor for changes in the therapeutic and adverse effects of meloxicam if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00582_DB00814]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00582_DB00814 label "DDI between Voriconazole and Meloxicam - Voriconazole may increase the serum concentration of meloxicam by decreasing its metabolism via CYP2C9 and CYP3A4. Monitor for changes in the therapeutic and adverse effects of meloxicam if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00582_DB00814]" assertion.